Patents by Inventor Pengyu YANG

Pengyu YANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10502997
    Abstract: A touch liquid crystal display (LCD) device, a touch display device and a lamination method are provided. The touch LCD device includes an LCD module, a package substrate, a first adhesive and a second adhesive; the LCD module and the package substrate are adhered to each other through the first adhesive which covers a display area of the LCD module; and the second adhesive is disposed between the LCD module and the package substrate and on a non-display area of the LCD module, and hardness of the second adhesive is greater than hardness of the first adhesive. The touch LCD device can effectively eliminate the problem of reduced display quality caused by the water wave phenomenon that the touch LCD device adopting a full lamination method tends to generate.
    Type: Grant
    Filed: March 23, 2016
    Date of Patent: December 10, 2019
    Assignees: BOE Technology Group Co., Ltd., Hefei Xinsheng Optoelectronics Technology Co., Ltd.
    Inventors: Jun Chen, Hongqiang Luo, Pengyu Zhang, Zhanqi Xu, Zhongzheng Yang, Kefeng Li, Ting Zeng
  • Publication number: 20190328888
    Abstract: Methods and compositions are provided for extending the half-life of a therapeutic agent. One or more half-life extending moieties may be attached to a therapeutic agent, thereby extending the half life of the therapeutic agent. The modified therapeutic agents (mTAs) comprising one or more half-life extending moieties attached to a therapeutic agent may be used to treat a disease or condition in a subject in need thereof.
    Type: Application
    Filed: May 7, 2019
    Publication date: October 31, 2019
    Inventors: Weijun SHEN, Peter G. SCHULTZ, Avinash MUPPIDI, Insha AHMAD, Pengyu YANG
  • Publication number: 20190315863
    Abstract: Methods, compositions and uses are provided for bispecific antibodies comprising one or more unnatural amino acids. The bispecific antibodies may bind to two or more different receptors, co-receptors, antigens, or cell markers on one or more cells. The bispecific antibodies may be used to treat a disease or condition (e.g., cancer, autoimmune disease, pathogenic infection, inflammatory disease). The bispecific antibodies may be used to modulate (e.g., stimulate or suppress) an immune response.
    Type: Application
    Filed: May 22, 2019
    Publication date: October 17, 2019
    Inventors: Chanhyuk KIM, Jun Y. AXUP, Hwayoung YUN, Peter G. SCHULTZ, Jennifer MA, Jiayin SHEN, Pengyu YANG
  • Publication number: 20190306859
    Abstract: A method and an apparatus for transmitting uplink information, the method including configuring, by a base station, a flexible subframe for a user equipment (UE), where the flexible subframe is a subframe in which the base station is configured to receive or transmit data according to a time division duplex (TDD) uplink-downlink subframe configuration of the subframe, and sending, by the base station, resource configuration indication information and subframe configuration indication information to the UE, where the resource configuration indication information indicates the flexible subframe and a subframe direction to which the flexible subframe currently needs to be applied, where the subframe direction is a direction of transmission with respect to the base station, and where the subframe configuration indication information instructs the UE to transmit uplink information according to the subframe configuration indication information.
    Type: Application
    Filed: June 19, 2019
    Publication date: October 3, 2019
    Inventors: Wei Quan, Xiaodong Yang, Zhenxing Hu, Jian Zhang, Pengyu Ji
  • Patent number: 10351626
    Abstract: Methods, compositions and uses are provided for bispecific antibodies comprising one or more unnatural amino acids. The bispecific antibodies may bind to two or more different receptors, co-receptors, antigens, or cell markers on one or more cells. The bispecific antibodies may be used to treat a disease or condition (e.g., cancer, autoimmune disease, pathogenic infection, inflammatory disease). The bispecific antibodies may be used to modulate (e.g., stimulate or suppress) an immune response.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: July 16, 2019
    Assignee: The Scripps Research Institute
    Inventors: Chanhyuk Kim, Jun Y. Axup, Hwayoung Yun, Peter G. Schultz, Jennifer Ma, Jiayin Shen, Pengyu Yang
  • Patent number: 10356780
    Abstract: The present invention discloses a method and an apparatus for transmitting uplink information. The method relates to a user equipment receives resource configuration indication information and subframe configuration indication information that are sent from a base station, where the resource configuration indication information is used to indicate at least one flexible subframe. The UE determines whether to transmit uplink information in the flexible subframe according to the subframe configuration indication information.
    Type: Grant
    Filed: October 13, 2017
    Date of Patent: July 16, 2019
    Assignee: HUAWEI TECHNOLOGIES CO., LTD.
    Inventors: Wei Quan, Xiaodong Yang, Zhenxing Hu, Jian Zhang, Pengyu Ji
  • Patent number: 10286078
    Abstract: Methods and compositions are provided for extending the half-life of a therapeutic agent. One or more half-life extending moieties may be attached to a therapeutic agent, thereby extending the half life of the therapeutic agent. The modified therapeutic agents (mTAs) comprising one or more half-life extending moieties attached to a therapeutic agent may be used to treat a disease or condition in a subject in need thereof.
    Type: Grant
    Filed: September 12, 2014
    Date of Patent: May 14, 2019
    Assignees: THE CALIFORNIA INSTITUTE FOR BIOMEDICAL RESEARCH, THE SCRIPPS RESEARCH INSTITUTE
    Inventors: Weijun Shen, Peter G. Schultz, Avinash Muppidi, Insha Ahmad, Pengyu Yang
  • Publication number: 20190000928
    Abstract: Methods and compositions are provided for extending the half-life of a therapeutic agent. A modified therapeutic agent (mTA) comprises a therapeutic agent, a staple, and a half-life extending molecule. The mTAs disclosed herein may be used to treat a disease or a condition in a subject in need thereof.
    Type: Application
    Filed: June 16, 2016
    Publication date: January 3, 2019
    Inventors: Weijun SHEN, Pengyu YANG, Peter G. SCHULTZ
  • Publication number: 20180344812
    Abstract: Methods and compositions are provided for extending the half-life of a therapeutic agent. A modified therapeutic agent (mTA) comprises a therapeutic agent, a staple, and a half-life extending molecule. The mTAs disclosed herein may be used to treat a disease or a condition in a subject in need thereof.
    Type: Application
    Filed: June 5, 2018
    Publication date: December 6, 2018
    Inventors: Weijun Shen, Pengyu Yang, Huafei Zou, Peter G. Schultz
  • Patent number: 10039809
    Abstract: Methods and compositions are provided for extending the half-life of a therapeutic agent. A modified therapeutic agent (mTA) comprises a therapeutic agent, a staple, and a half-life extending molecule. The mTAs disclosed herein may be used to treat a disease or a condition in a subject in need thereof.
    Type: Grant
    Filed: December 17, 2014
    Date of Patent: August 7, 2018
    Assignees: THE CALIFORNIA INSTITUTE FOR BIOMEDICAL RESEARCH, THE SCRIPPS RESEARCH INSTITUTE
    Inventors: Weijun Shen, Pengyu Yang, Huafei Zou, Peter G. Schultz
  • Patent number: 10010589
    Abstract: Methods and compositions are provided for extending the half-life of a therapeutic agent. A modified therapeutic agent (mTA) comprises a therapeutic agent, a staple, and a half-life extending molecule. The mTAs disclosed herein may be used to treat a disease or a condition in a subject in need thereof.
    Type: Grant
    Filed: December 17, 2014
    Date of Patent: July 3, 2018
    Assignees: THE CALIFORNIA INSTITUTE FOR BIOMEDICAL RESEARCH, THE SCRIPPS RESEARCH INSTITUTE
    Inventors: Weijun Shen, Pengyu Yang, Huafei Zou, Peter G. Schultz
  • Publication number: 20170002076
    Abstract: Methods, compositions and uses are provided for bispecific antibodies comprising one or more unnatural amino acids. The bispecific antibodies may bind to two or more different receptors, co-receptors, antigens, or cell markers on one or more cells. The bispecific antibodies may be used to treat a disease or condition (e.g., cancer, autoimmune disease, pathogenic infection, inflammatory disease). The bispecific antibodies may be used to modulate (e.g., stimulate or suppress) an immune response.
    Type: Application
    Filed: September 16, 2016
    Publication date: January 5, 2017
    Inventors: Chanhyuk KIM, Jun Y. AXUP, Hwayoung YUN, Peter G. SCHULTZ, Jennifer MA, Jiayin SHEN, Pengyu YANG
  • Publication number: 20160317623
    Abstract: Methods and compositions are provided for extending the half-life of a therapeutic agent. A modified therapeutic agent (mTA) comprises a therapeutic agent, a staple, and a half-life extending molecule. The mTAs disclosed herein may be used to treat a disease or a condition in a subject in need thereof.
    Type: Application
    Filed: December 17, 2014
    Publication date: November 3, 2016
    Inventors: Weijun SHEN, Pengyu YANG, Huafei ZOU, Peter G. SCHULTZ
  • Publication number: 20160287713
    Abstract: Methods and compositions are provided for extending the half-life of a therapeutic agent. One or more half-life extending moieties may be attached to a therapeutic agent, thereby extending the half life of the therapeutic agent. The modified therapeutic agents (mTAs) comprising one or more half-life extending moieties attached to a therapeutic agent may be used to treat a disease or condition in a subject in need thereof.
    Type: Application
    Filed: September 12, 2014
    Publication date: October 6, 2016
    Inventors: Weijun SHEN, Peter G. SCHULTZ, Avinash MUPPIDI, Andreas CRAMERI, Insha AHMAD, Pengyu YANG
  • Publication number: 20160115232
    Abstract: Methods, compositions and uses are provided for bispecific antibodies comprising one or more unnatural amino acids. The bispecific antibodies may bind to two or more different receptors, co-receptors, antigens, or cell markers on one or more cells. The bispecific antibodies may be used to treat a disease or condition (e.g., cancer, autoimmune disease, pathogenic infection, inflammatory disease). The bispecific antibodies may be used to modulate (e.g., stimulate or suppress) an immune response.
    Type: Application
    Filed: March 14, 2014
    Publication date: April 28, 2016
    Inventors: Chanhyuk KIM, Jun Y. AXUP, Hwayoung YUN, Peter G. SCHULTZ, Jennifer MA, Jiayin SHEN, Pengyu YANG